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OBJECTIVE: Celiac disease is a permanent enteropathy caused by the ingestion of gluten, which leads to an immune-
mediated inflammation of the small intestine mucosa. The prevalence of celiac disease varies among different
nations and ethnic backgrounds, and its diversity is determined by genetic and environmental factors. Sa˜o Paulo city
is one of the largest cities in the world, with a vast population and an important history of internal migratory flow
from other Brazilian regions, as well as immigration from other, primarily European, countries, resulting in
significant miscegenation. The aim of the present study was to estimate the prevalence of adults with undiagnosed
celiac disease among blood donors of Sa˜o Paulo by collecting information on the ancestry of the population
studied.
METHODS: The prevalence of celiac disease was assessed by screening for positive IgA transglutaminase and IgA
endomysium antibodies in 4,000 donors (volunteers) in the Fundac¸a˜o Pro´-Sangue Blood Center of Sa˜o Paulo, Sa˜o
Paulo, Brazil. The antibody-positive subjects were asked to undergo a small bowel biopsy.
RESULTS: Of the 4,000 subjects, twenty-four had positive tests, although both antibody tests were not always
concordant. For example, ten subjects were positive for IgA tissue transglutaminase only. In twenty-one positive
patients, duodenal biopsies were performed, and the diagnosis of celiac disease was confirmed in fourteen patients
(Marsh criteria modified by Oberhuber). In this group, 67% claimed to have European ancestry, mainly from Italy,
Portugal and Spain.
CONCLUSION: The prevalence of celiac disease is at least 1:286 among supposedly healthy blood bank volunteers in
Sa˜o Paulo, Brazil.
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INTRODUCTION
Celiac disease (CD) is characterized by chronic inflam-
matory lesions in the small intestine of genetically predis-
posed subjects. It is induced by gluten-rich food ingestion
and is reversible upon withdrawal of gluten from the diet.
Environmental, genetic and immunological factors are
involved in the pathogenesis of CD (1-3).
During the last few decades, studies carried out in
different countries have shown that the actual prevalence
of CD is higher than previously thought (2,4,5). Surveys
have been conducted among subjects from the general
population and those belonging to risk groups using
serological markers. These studies showed that the disease
is underdiagnosed when heterogeneous clinical features are
present, as CD may manifest in a variety of ways, ranging
from typical signs and symptoms of malabsorption to even
an absence of symptoms (5,6). Estimates based on serolo-
gical epidemiological studies suggest that for each diagnosis
made from typical clinical findings of CD, there are 3 to 7
oligo- or asymptomatic patients who are undiagnosed (3).
CD exhibits features of an autoimmune disease and may
involve many organs other than the gastrointestinal tract
(3,7). Furthermore, it shows variable morbidity, with several
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delayed complications when not treated early (2,8,9). This
fact, coupled with the availability of noninvasive serological
tests with high sensitivity and specificity, corroborates the
importance of epidemiological studies in the general
population and in specific risk groups to better understand
the disease and to improve the diagnosis of atypical cases
(2,5,7).
Most of the existing CD prevalence studies were
conducted in apparently healthy blood bank donors who
had not been previously selected for other studies. Several
countries have reported a high prevalence of CD among
donors: Israel, 1:157 (10); Iran, 1:166 (11); Tunisia, 1:355 (12);
the United States of America, 1:125 (13); Denmark, 1:394;
and Sweden 1:373 (14). In Brazil, screening studies carried
out at blood banks indicated that the prevalence ranged
from 1:681 (15) to 1:276 (16) donors.
Sa˜o Paulo city, one of the largest metropolises in the
world, is an urban center in Brazil that displays great ethnic
diversity due to frequent European immigration (17). Apart
from this, the city is an important center of internal
migration, which, in turn, increases miscegenation even
more. In addition to these facts, the amount of gluten-rich
food normally ingested by the population is similar to that
in European countries (18), where there is a high prevalence
of the disease. As a possible triggering factor, there is also a
high incidence of gastrointestinal infections during child-
hood, which may be involved in the pathogenesis of CD
(19).
Considering the fundamental importance of the genetic
component of CD and the marked miscegenation present
in Brazil, the aim of this study was to estimate the
prevalence of the disease in the adult population of Sa˜o
Paulo city and the correlation with racial/ethnic groups.
PATIENTS AND METHODS
Patients
From September 2003 to August 2004, at the Fundac¸a˜o Pro´-
Sangue Blood Center of Sa˜o Paulo, Sa˜o Paulo, Brazil, 4,000
serum samples obtained from blood donors of both genders
aged 18 to 65 years (median, 31 years), regardless of gender,
were processed. The only inclusion criterion for the study
was that donors had to have a fixed residence for at least
two years in the city of Sa˜o Paulo. Individuals with known
CD were excluded from participation.
After signing the written consent and filling out a pre-
established questionnaire, blood samples were drawn at the
blood bank center. Serum samples were immediately
centrifuged and stored at -20 C˚ until serological tests were
carried out.
The research protocol was approved by the Ethics
Committee of the Hospital das Clı´nicas at the University of
Sa˜o Paulo School of Medicine and by the Ethics Committee
of the Fundac¸a˜o Pro´-Sangue Blood Center of Sa˜o Paulo, Sa˜o
Paulo, Brazil.
Study design
This cross-sectional study evaluated the positivity of
serological tests of 4,000 serum samples obtained at the
blood bank during a 12-month period. All donors were
asked to fill out a pre-established form to collect information
about demographic data, including questions on self-
reported ethnic categories based on the predetermined
five-term system of the Brazilian Institute of Geography and
Statistics (IBGE) (20): White, Mixed, Black, Yellow (meaning
East Asians), and Amerindians. Ancestral roots were
established by questions about the donors’ ancestors’ places
of birth up to the third generation.
Subjects with positive tissue anti-transglutaminase (tTG)
and/or anti-endomysial antibodies (AEA) were asked to
answer a more detailed and extensive questionnaire about
symptoms. These subjects were also requested to undergo
an upper digestive endoscopy with a duodenal biopsy.
The chi-square and Fisher’s exact tests were employed for
analyzing nominal and proportion data sets obtained from
both donor and CD patient groups.
Serological assays
Serological tests were carried out at the Laborato´rio de
Gastroenterologia Clı´nica e Experimental - LIM 07, Hospital das
Clı´nicas, University of Sa˜o Paulo School of Medicine.
Enzyme-linked immunosorbent assays (ELISAs) to detect
IgA anti-guinea pig liver tTG antibodies and IgA AEA on
human umbilical cords were performed for all samples.
Tissue anti-transglutaminase antibody (tTG) assay. De-
scribed originally by Dieterich et al. (21) and modified by
Pereira et al. (22), this test employs guinea pig liver tissue
transglutaminase (Product No. T-5398. Sigma-Aldrich Co., St.
Louis, MO, USA) and goat anti-human IgA (a-chain specific)
peroxidase conjugate (Product No. A-0295. Sigma-Aldrich
Co.), diluted at 1:1,000. Quality control was assessed by
utilizing two control serum samples in every assay. Intra- and
inter-assay variations were 8.68% (n = 22) and 8.38% (n = 24),
respectively.
Anti-endomysial antibody assay. This assay was per-
formed according to the method described by Pereira
et al. (22). Immunofluorescence tests for anti-endomysial
antibodies were carried out using 2-mm cryosections of
human umbilical cord, which were incubated with 1:5 pre-
diluted serum in Tween-PBS. The samples were incubated
with goat anti-human fluorescein-conjugated IgA (Product
No. F-9637, Sigma-Aldrich Co., St. Louis, MO, USA) diluted
1:30. Samples were considered positive if there was a
hexagonal pattern of fluorescence throughout the peritubular
muscle layer of the human umbilical cord vessels, marking the
extracellular connective tissue. Analyses were conducted by
three observers using an immunofluorescence microscope
(enhancement of 400x) to define both positivity and anti-
endomysial antibody titration.
HLA typing
HLA-DQ was performed in 21 blood donors with positive
serological tests. The HLA-A, HLA-B and HLA-DQB1
Dynal RELI SSO typing kits (Product Nos. 830.01, 840.01,
and 820.01; Dynal Biotech Ltd., Bromborough, Wirral, U.K.)
were used to determine HLA. The gDNA was extracted
using the ChargeSwitchH gDNA 50-100 ml blood kit (Product
No. CS11000; Invitrogen Corporation, Carlsbad, CA, USA).
HLA-DQ typing was also performed in samples from
180 inhabitants of Sa˜o Paulo city to verify the DQ2/DQ8
prevalence in the population.
Upper digestive endoscopy
An upper digestive endoscopy was performed to confirm
the diagnosis in antibody-positive patients. Multiple duo-
denal biopsies were collected (two duodenal and six from
the second section of the duodenum). The material obtained
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was placed on filter paper and fixed in 10% formalin for
later processing.
Histology
Formalin-fixed samples were stained with hematoxylin
and eosin for histological study. The following features
were evaluated: (1) crypt/villous ratio, (2) crypt regenera-
tion, (3) characteristics of the inflammatory infiltrate in the
section itself, and (4) type of atrophy. Two pathologists
examined every slide to ensure standardization of the
histological aspects of the samples using the histological
classification of Marsh, modified by Oberhuber (23). This
modified system establishes five lesion classes. In Marsh 0,
there is normal architecture of the mucosa and less than 40
intraepithelial lymphocytes per 100 enterocytes in the villus
epithelium. Marsh I is defined as normal architecture of the
mucosa and more than 40 lymphocytes per 100 enterocytes
in the villous epithelium. Marsh II involves crypt enlarge-
ment (hyperplasia), in which immature epithelial cells are
produced in large numbers, and there is an influx of
lymphocytes and plasmocytes. In this system, Marsh III has
been reclassified and divided into three separate classes. In
Marsh IIIa, there is partial villous atrophy combined with
slight lymphocyte infiltration in epithelial cells and crypt
hyperplasia. Marsh IIIb is marked by near total atrophy of
the villi (villi still recognizable); crypt hyperplasia, in which
immature epithelial cells are produced in greater propor-
tions; and an influx of inflammatory cells. The final
designation, Marsh IIIc, indicates total villous atrophy,
hyperplasic crypts and infiltrative lesions. Samples with a
preserved villous/crypt relationship, but with higher counts
of intra-epithelial lymphocytes (IELs) in the hematoxylin
and eosin staining, were also stained for immunohisto-
chemistry to better determination of the IEL count (23).
RESULTS
Blood bank population screening was carried out in 1,817
women (46.4%) and 2,183 men (54.6%) aged 18 to 65 years
(median, 31 years). As shown in Table 1 and Figure 1, 75.3%
of subjects were classified as White, 18.4% as Brown, 4.7% as
Black, and 1.3% as Yellow. Sixteen subjects (0.4%) were
considered of unknown ethnicity, as they declared not
knowing their own ethnicity for unknown reasons.
The vast majority of participants reported having been
born in the southeast region of Brazil (77.8%), followed
by the northeast region (17.7%). Based on the subjects’
responses regarding relatives, 87.3 and 94.9% of the subjects’
mothers and fathers, respectively, were Brazilians. With
regard to first, second and third generations, most relatives
not born in Brazil were born in European countries
(Figure 2).
The 4,000 serum samples were examined using both tTG
and AEA. The AEA positive predictive value was 100%, and
the tTG positive predictive value was 85%. Test concor-
dance was found in 11 cases, ten cases were only tTG+ and
three cases were only AEA+.
Of the 24 donors with positive tests, 21 agreed to undergo
an upper digestive endoscopy with duodenal biopsy; ten of
them were tTG+/AEA+, three were tTG-/AEA+, and eight
were tTG+/AEA-. Concerning duodenal endoscopic evalua-
tion, only 29% displayed any changes; the most common
finding was the mosaic appearance of the mucosa and, in
one case, a decrease in duodenal folds.
Histological analysis, based on the Marsh criteria mod-
ified by Oberhuber (22), revealed two cases with an increase
in intra-epithelial lymphocytes (.40 IELs/100 enterocytes),
which were classified as type I; six cases with discreet
villous atrophy were classified as type IIIa; three cases with
marked villous atrophy were classified as type IIIb; and five
cases with complete villous atrophy were classified as type
IIIc (Figure 1). The remaining cases did not fit the criteria
employed.
HLA typing was conducted in 21 patients, but only 14
exhibited HLA-DQ2 or -DQ8. Two of these patients were
homozygous for HLA-DQB1*02 (DQ2), and one was
homozygous for HLA-DQB1*0302 (DQ8). The HLA typing
results in both cases of type I histological lesions did not
confirm HLA DQ2/DQ8, nor did the results from four
donors with nonspecific histological findings for CD.
In this study, 14 cases of CD were confirmed based on
serological tests, HLA and atrophy observed on duodenal
biopsy. The patients with CD were aged 18 to 51 years
(median, 26 years), and 64.3% of them were women (M/F,
1:1.8). No patients mentioned a previous diagnosis of CD, and
there were no complaints or symptoms of hepatic or thyroid
disorders, small stature, infertility, osteoporosis or diabetes.
No patients exhibited malabsorption, and two patients were
asymptomatic. The majority of patients presented with a
mild clinical picture, and the most common gastrointestinal
symptoms were flatulence (78%), epigastralgia (28.6%), mouth
ulcers (28.6%), and mild abdominal pain (21.4%). The most
frequent extra-intestinal signs and symptoms were irritability
(36%), anemia, fatigue (35.7%), and arthralgia (35%).
Sixty-four percent of the subjects reported European
ancestry, primarily from Italy, Portugal, and Spain.
Table 1 - Ethnic distribution (20) of blood donors in Sa˜o
Paulo city from September 2003 to August 2004.
ETHNICITY (20) N (%)
White 3011 (75.3)
Brown (mixed ethnicities) 737 (18.4)
Black 186 (4.7)
Yellow 50 (1.3)
Unknown 16 (0.4)
TOTAL 4000 (100.0)
Figure 1 - Ethnic distribution in the study population with and
without celiac disease.
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Approximately 7% of the subjects did not have any
information about their ancestry.
The prevalence of HLA DQ2/DQ8 was estimated to be
36% (65 subjects) in the control group of 180 inhabitants of
Sa˜o Paulo city. Serological marker tests conducted in this
sample group revealed one positive case of CD.
DISCUSSION
Based on the results of the present study, a CD prevalence
of 1/286 was estimated among supposedly healthy blood
bank volunteers aged 18 to 65 years in Sa˜o Paulo, Brazil,
which is 2.4 times lower than the prevalence reported in the
USA (24) and is similar to that reported in Europe (25).
Sa˜o Paulo city was an important migratory destination for
European Caucasians from the end of the 19th century to the
middle of the 20th century. As reported in the present study,
HLA DQ2/DQ8 prevalence was estimated as 36% in the Sa˜o
Paulo population, which is close to that in European
countries (30%) (26). These data confirm a genetic predis-
position to develop CD.
Sa˜o Paulo city is also the largest urban center in Brazil and
an important internal migration area, favoring great mis-
cegenation. The ethnic category distribution reported in the
2005 census in the southern region of Brazil was 80.7%
White, 15.0% Brown (Multiracial), 3.6% Black, and 0.4%
Yellow (27). As shown in Table 1, the present study revealed
a very similar distribution, demonstrating indirectly that the
population studied resembles that of the southern region
of the country. In Brazil, the classification of Brown
(Multiracial), namely Pardo in Portuguese, constitutes a
mixture of all three colonial ethnicities (i.e., White, Black,
and Amerindian), but people of this classification are
currently of predominantly European ancestry (28).
Studies investigating the prevalence of CD in Curitiba
(State of Parana´, Brazil), conducted in a population whose
ancestry was 100% European, showed an estimated pre-
valence of 1:417 (22); however, studies in Ribeira˜o Preto (State
of Sa˜o Paulo, Brazil), where 54.5% of the population is of
European ancestry, yielded an estimated prevalence of 1:273
(16), which is very close to that reported in the present study.
Furthermore, an increase in the ingestion of wheat in the
country in recent decades may have favored the increase in
CD in our society (18,22). This information suggests that if
genetic and environmental factors remain unchanged (e.g.,
ingestion of gluten-rich food), the prevalence of CD in
different geographic regions may be the same.
The biopsy-confirmed CD prevalence was at least 1:286
(3.5:1,000; 95% CI = 1.66-5.33) among healthy blood donors,
indicating that there is a high CD prevalence in Brazil,
which has been confirmed by other national studies.
The prevalence of CD may be even higher in the city of Sa˜o
Paulo, considering that the study was conducted at a blood
bank with supposedly healthy subjects and excluded subjects
with anemia (one of the most common extra-intestinal sym-
ptoms) (29), hepatitis C virus (HCV) (exogenously adminis-
tered IFN-a may trigger CD in predisposed subjects by
enhancing Th1 responses) (30,31), and type 1 diabetes
mellitus (CD prevalence of 4% in T1DM) (32). Moreover, a
measurement of the total IgA was not performed, and its
deficiency is higher among celiac patients (3%) (33), which
may have produced false-negative results in our study.
Additionally, three subjects with positive serological tests
refused to undergo a duodenal biopsy to confirm the
presence of the disease.
On the other hand, to ensure a more accurate screening
diagnosis of CD in blood bank settings, two serological tests
were employed, namely tTG and AEA, both of which are
considered to have good sensitivity and specificity (33,34). If
only AEA had been evaluated, four tTG+ subjects would not
have been included in the cohort, whereas three patients
would not have been properly diagnosed if only tTG had
been assessed. CD would be underdiagnosed if only one
serological marker was employed in general population
screening studies. This finding is corroborated by a study
conducted in Israel suggesting that the use of only one
serological test for screening the so-called healthy popula-
tion is not enough to establish the true prevalence of CD
(10).
All celiac patients with biopsies indicating villous atrophy
had confirmed HLA-DQ2 or DQ8 HLA typing results; two
individuals with type I histological lesions did not have
HLA DQ2/DQ8, ruling out the hypothesis of CD because
the negative predictive value of this test is high (35).
In Brazil, three other population screening studies con-
ducted at blood banks revealed the following prevalences of
Figure 2 - Ancestrally distribution in the study population.
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undiagnosed CD: 1:417 in Curitiba, 1:276 in Ribeira˜o Preto
and 1:681 in Brası´lia (15,16,22).
Population screening carried out by our group in Curitiba
showed that the prevalence of CD was lower than that in the
city of Sa˜o Paulo. This finding had not been anticipated,
given the dominant European ancestry and lower internal
migration in Curitiba, which suggests an underestimation of
CD in this city. This is most likely due to the use of a single
serological test for the initial screening, as the guinea pig
anti-transglutaminase test shows a lower sensitivity com-
pared with both the human anti-transglutaminase test and
AEA (22).
The survey carried out in Ribeira˜o Preto, whose popula-
tion of 500,000 inhabitants is approximately 5% of that of
Sa˜o Paulo city, employed an equivalent methodology
concerning serological test sensitivity and showed a similar
CD prevalence, providing evidence for the validity of the
present study (16).
However, two population-screening studies conducted in
Brası´lia yielded conflicting results. The first, demonstrating
a prevalence of 1:681, was conducted in healthy blood
donors and employed anti-gliadine as the initial test, which
has a sensitivity and specificity between 52-100 and 71-
100%, respectively (15). The second epidemiological survey
was conducted in adult and pediatric patients at the
University Hospital and used IgA AEA as the initial
screening test, which showed a CD prevalence of 3.6 per
1,000 (approximately 1:278) (36). Such different results in the
same city may be attributed to differences in the methodol-
ogy and population between the two groups.
In the USA, the first population study of CD with blood
donors, using IgA anti-gliadine (AGA) as an initial serologi-
cal test, showed a CD prevalence of 1:250. However, the use
of the human anti-transglutaminase test in the same sample
showed a CD prevalence of 1:125, indicating that serological
screening with AGA underestimated the CD prevalence in
the USA (13).
When clinical presentation was evaluated, no patients
showed typical manifestations of intestinal malabsorption.
Flatulence, irritability, anemia, fatigue, and arthralgia were
the most common unspecific symptoms/signs, which is
evidence of the heterogeneous presentation of the disease
(8,37).
Currently, the detection of atrophic alterations of the
duodenal and jejunal mucosa, equivalent to type III Marsh
lesions observed on biopsy, remains the gold standard in
the diagnosis of CD (38). In the outpatient clinic at the
University of Sa˜o Paulo School of Medicine, six cases with
positive serological tests, lacking either HLA DQ2/DQ8
haplotypes or villous atrophy, as well as one case with a
positive serological test, HLA DQ2, and without villous
atrophy, have been followed-up to evaluate the possibility
of latent disease (23,34).
The present study suggests that the serological marker
choice is vital to minimize the number of false-positive and
-negative results, especially when the studied sample group
is chosen from the general population and is therefore
considered healthy. Combining two serological tests
increased the sensitivity for the detection of CD and
provided a better estimate of the prevalence of the disease
in the city of Sa˜o Paulo.
Although blood bank donors are generally highly selected
groups that have been screened for risk factors and
serological markers associated with a variety of infectious
diseases, the present study demonstrated that the prevalence
of CD in Sa˜o Paulo city is similar to that in European
countries. At the same time, the findings confirmed the
importance of undiagnosed atypical cases in the population
of Sa˜o Paulo city.
It is reasonable to assume that the main factors contribut-
ing to the obtained prevalence were the high ingestion of
wheat, as in other countries with a high incidence of the
disease, and the population ancestry, as most citizens come
from European countries with a high prevalence of CD.
This prevalence study is important because it was
conducted in the largest urban center in Brazil, which
represents 6% of the country’s population and is represen-
tative of the population of the southern region of Brazil,
which is the region with the highest European ancestry.
Nevertheless, it is crucial that CD prevalence be mapped in
other cities to assess regional population differences, as the
central-western, northern and northeastern states of the
country have greater ethnic differences, mainly due to
miscegenation with people of African and Amerindian
(indigenous) ethnicity.
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